These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19199040)

  • 1. Paraneoplastic syndromes in thymoma: an immunological perspective.
    Nelson RP; Pascuzzi RM
    Curr Treat Options Oncol; 2008 Dec; 9(4-6):269-76. PubMed ID: 19199040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An interesting collection of paraneoplastic syndromes in a patient with a malignant thymoma.
    Kidher ES; Briceno N; Taghi A; Chukwuemeka A
    BMJ Case Rep; 2012 Jul; 2012():. PubMed ID: 22761203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraneoplastic diseases associated with thymoma.
    Evoli A; Minicuci GM; Vitaliani R; Battaglia A; Della Marca G; Lauriola L; Fattorossi A
    J Neurol; 2007 Jun; 254(6):756-62. PubMed ID: 17325820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
    Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
    Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From basic immunobiology to the upcoming WHO-classification of tumors of the thymus. The Second Conference on Biological and Clinical Aspects of Thymic Epithelial Tumors and related recent developments.
    Marx A; Müller-Hermelink HK
    Pathol Res Pract; 1999; 195(8):515-33. PubMed ID: 10483582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymoma, myasthenia gravis, eruptions of pemphigus vulgaris and a favourable course of relapsing melanoma: an immunological puzzle.
    Meyer S; Kroiss M; Landthaler M; Vogt T
    Br J Dermatol; 2006 Sep; 155(3):638-40. PubMed ID: 16911302
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunology of paraneoplastic syndromes: overview.
    Posner JB
    Ann N Y Acad Sci; 2003 Sep; 998():178-86. PubMed ID: 14592873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathomechanisms of paraneoplastic myasthenia gravis.
    Ströbel P; Preisshofen T; Helmreich M; Müller-Hermelink HK; Marx A
    Clin Dev Immunol; 2003 Mar; 10(1):7-12. PubMed ID: 14575152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia.
    Mygland A; Vincent A; Newsom-Davis J; Kaminski H; Zorzato F; Agius M; Gilhus NE; Aarli JA
    Arch Neurol; 2000 Apr; 57(4):527-31. PubMed ID: 10768628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune disorders of neuromuscular transmission.
    Mahadeva B; Phillips LH; Juel VC
    Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of thymic pathology with HLA in myasthenia gravis.
    Machens A; Löliger C; Pichlmeier U; Emskötter T; Busch C; Izbicki JR
    Clin Immunol; 1999 Jun; 91(3):296-301. PubMed ID: 10370374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraneoplastic and Therapy-Related Immune Complications in Thymic Malignancies.
    Lippner EA; Lewis DB; Robinson WH; Katsumoto TR
    Curr Treat Options Oncol; 2019 Jun; 20(7):62. PubMed ID: 31227926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymoma, myasthenia gravis, and other paraneoplastic syndromes.
    Tormoehlen LM; Pascuzzi RM
    Hematol Oncol Clin North Am; 2008 Jun; 22(3):509-26. PubMed ID: 18514130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis.
    Okumura M; Fujii Y; Shiono H; Inoue M; Minami M; Utsumi T; Kadota Y; Sawa Y
    Gen Thorac Cardiovasc Surg; 2008 Apr; 56(4):143-50. PubMed ID: 18401674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic autoimmunity in thymus tumors.
    Marx A; Schultz A; Wilisch A; Helmreich M; Nenninger R; Müller-Hermelink HK
    Dev Immunol; 1998; 6(1-2):129-40. PubMed ID: 9716914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CA-antibody: an immunological marker of thymic neoplasia in myasthenia gravis?
    Aarli JA; Gilhus NE; Hofstad H
    Acta Neurol Scand; 1987 Jul; 76(1):55-7. PubMed ID: 3630645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myasthenia gravis, thymoma and immunodeficiency].
    Lehtonen A; Soppi E; Panelius M
    Duodecim; 1984; 100(22):1544-50. PubMed ID: 6518999
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of miRNAs in Normal and Myasthenia Gravis Thymus.
    Cron MA; Guillochon É; Kusner L; Le Panse R
    Front Immunol; 2020; 11():1074. PubMed ID: 32587589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to ion channels in paraneoplastic disorders.
    Vincent A
    Brain Pathol; 1999 Apr; 9(2):285-91. PubMed ID: 10219746
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnosis of thymoma and thymic atrophy in patients with myasthenia gravis].
    Sund KK; Skeie GO; Gilhus NE; Aarli JA; Varhaug JE
    Tidsskr Nor Laegeforen; 1997 Nov; 117(29):4212-4. PubMed ID: 9441462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.